DP
Dennis Podlesak (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Syndax Pharmaceuticals, Inc. (SNDX). The largest single filing was $114K of SNDX (8,000 sh × $14.21, as filed), executed Oct 29. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$114K
shares × price, as filed
Last traded
Oct 29
Filed Oct 30
Median ADV $36.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $989K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
SNDXRecent filings
SNDXSALE
Syndax Pharmaceuticals, Inc.
View filing →
$114K8,000 sh × $14.21
Exec Oct 29
Filed Oct 30 · 7:09 PM ET SNDXSALE Syndax Pharmaceuticals, Inc. View filing → $875K
57,600 sh across 3 lots
Exec Aug 14 2025
Filed Aug 18 2025 · 5:30 PM ET